Month: August 2021

$ALYI – Alternet Systems, Inc.$ALYI – RVLT// 0.2 MODUSDallas, TX , Aug. 12, 2021 (GLOBE NEWSWIRE) — Alternet Systems, Inc. (OTC Pink: ALYI) (“ALYI”) and EV design partner MODUS are set to review the update production design of the Retro Revolt Electric Motorcycle today.  The latest design was demonstrated in a video published earlier this year: https://youtu.be/ZvL3Ij3bnGo MODUS has been working to update the pilot design featured in the video with a rear hub motor to improve battery capacity in the frame.  The updated hub motor Retro Revolt Electric Motorcycle will be reviewed by ALYI management tomorrow.  A new sneak peek video will be coming soon along with a production schedule supporting planned sales of the Retro Revolt Electric Motorcycle in North America. The Retro Revolt Electric Motorcycle...

Leverkusen, Germany, Aug. 12, 2021 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the first six months ended June 30, 2021 on Thursday, August 19, 2021. Conference calls for shareholders and interested investors will be held on Friday, August 20, 2021, at the following times: In German, August 20, 2021 at 10:00 am CEST (4:00 am EST)Dial-in number Germany: +49 69201744220Conference code: 63828444# In English, August 20, 2021 at 2:00 pm CEST (8:00 am EST)Dial-in number USA: +1 8774230830Dial-in number UK: +44 2030092470Conference code: 78540812# Please dial in 10 minutes ahead of time to ensure a timely start of the conference call.-End- Biofrontera AGPamela Keck, Head of Investor Relationsir@biofrontera.com+49-214-87632-0 About...

CORSICANA, TX, Aug. 12, 2021 (GLOBE NEWSWIRE) — Midwest Energy Emissions Corp. (OTCQB: MEEC) (“ME2C Environmental” or the “Company”), a leading environmental technologies firm, today announced that management will present at the Q3 Virtual Investor Summit, taking place August 17-18, 2021. Richard MacPherson, President and Chief Executive Officer of ME2C Environmental, is scheduled to participate in one-on-one meetings with investors throughout the event and will host a virtual presentation as follows: Investor SummitDate: Wednesday, August 18, 2021Time: 9:30 a.m. Eastern time Webcast: https://zoom.us/webinar/register/WN_gBk7hdw1R0i175M1yx6MAA Registration is mandatory for conference participation. For more information on the conference, please visit www.investorsummitgroup.com or contact your Investor Summit representative. About...

VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has shipped its initial order of one-gram, full spectrum oil (FSO) vape carts via its distribution partner to the British Columbia Liquor Distribution Branch (LDB). As consumer preferences mature, demand for Pure Extracts’ Pure Pulls branded vape carts is high within the provincial markets as this product also offers exceptional value to the consumer while generating high margins for the Company. The cartridges were filled with a selection of some of the Company’s 30+...

Los Angeles, CA., Aug. 12, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced that it is launching its new, North American designed and built, Draganflyer Commander2 drone system. One of the most important features of the new Draganflyer Commander2 system is that it has been exclusively designed, developed, and manufactured in Canada, and fully complies with “Built-in-North America” requirements to take maximum advantage of federal regulatory requirements concerning the origin and security of drone systems and devices. The Draganflyer Commander2 is a small Unmanned Aerial System (sUAS) and replaces the highly respected Commander platform launched in 2015. The new model improves operational...

FALLS CHURCH, Va., Aug. 12, 2021 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) announced it has elected Graham Robinson to its board of directors. Robinson is the senior vice president and president of STANLEY Industrial, a business segment of Stanley Black & Decker, a position he has held since April 2020. “Graham’s range of global business and technical experience, including his current role leading a business for a publicly traded industrials company, will be a valuable asset as a member of our board,” said Kathy Warden, chairman, chief executive officer and president, Northrop Grumman. Prior to joining Stanley Black & Decker, Robinson served as an executive with Honeywell for seven years, including roles as president of Honeywell Industrial Safety, president of Honeywell Sensing and IoT, and chief marketing...

Company to host webcast on Monday, August 16th at 8:30 am ET NEVE ILAN, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that the Company will host a Business Update Video Presentation on Monday, August 16th at 8:30 am ET with Ran Poliakine, Chairman and Chief Executive Officer and other members of Nanox’s senior leadership. Video Presentation details: Monday, August 16th8:30am EThttps://media.rampard.com/202108162/ Interested parties can register for the presentation here.         About Nanox: Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes...

ODD Follows RMAT Designation Granted to ALLO-715 by the U.S. Food and Drug Administration in Multiple Myeloma Patients Phase 1 Data from the ALLO-715 UNIVERSAL Trial Demonstrated for the First Time that an Allogeneic CAR T Therapy Directed at BCMA Can Achieve Clinical Responses While Eliminating the Need for Bridging Therapy or Delays in Treatment Associated with Manufacturing Next Clinical Update from the ALLO-715 UNIVERSAL Trial Planned for Late 2021SOUTH SAN FRANCISCO, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to ALLO-715 for the treatment of multiple myeloma. Initial...